Preferential coupling between dopamine D2 receptors and G-proteins - PubMed (original) (raw)
Preferential coupling between dopamine D2 receptors and G-proteins
J P Montmayeur et al. Mol Endocrinol. 1993 Feb.
Abstract
The D2 dopamine receptor, an inhibitor of adenylyl cyclase, belongs to the family of seven transmembrane domain G-protein-coupled receptors. This receptor is encoded by two mRNAs produced from the same gene by alternative splicing, here referred to as D2L and D2S. The resultant proteins are identical except for an insertion of 29 amino acids in the putative third intracytoplasmic domain. This domain has been shown to be important for the coupling of this family of receptors to G-proteins. We have previously shown that there is differential inhibition of the adenylyl cyclase activity when these two receptors are produced in JEG3 cells; D2S is more efficient than D2L. To understand the molecular basis of such differential activity, we analyzed the G-proteins expressed in these cells. Here we show that G alpha i2 is absent in this cell line. Moreover, it is possible to restore the same inhibitory activity obtained by D2S when an expression vector encoding this alpha-subunit is cotransfected with D2L. In addition, transfections of the two receptors in a recipient cell line containing the three G alpha i subtypes confirm that the two receptors behave similarly. We conclude that the 29-amino acid insertion present in D2L allows it to interact specifically with G alpha i2. These data suggest that in vivo the function of activated D2 receptors is exerted by specific interactions with Gi-protein subtypes.
Similar articles
- Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins.
Guiramand J, Montmayeur JP, Ceraline J, Bhatia M, Borrelli E. Guiramand J, et al. J Biol Chem. 1995 Mar 31;270(13):7354-8. doi: 10.1074/jbc.270.13.7354. J Biol Chem. 1995. PMID: 7706278 - Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
O'Hara CM, Tang L, Taussig R, Todd RD, O'Malley KL. O'Hara CM, et al. J Pharmacol Exp Ther. 1996 Jul;278(1):354-60. J Pharmacol Exp Ther. 1996. PMID: 8764370 - Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line.
Hayes G, Biden TJ, Selbie LA, Shine J. Hayes G, et al. Mol Endocrinol. 1992 Jun;6(6):920-6. doi: 10.1210/mend.6.6.1323056. Mol Endocrinol. 1992. PMID: 1323056 - [The molecular biology of dopamine receptors].
Fujiwara Y, Sora I, Tomita H. Fujiwara Y, et al. Yakubutsu Seishin Kodo. 1991 Jun;11(3):187-96. Yakubutsu Seishin Kodo. 1991. PMID: 1685287 Review. Japanese. - Dopamine D2 receptors in signal transduction and behavior.
Picetti R, Saiardi A, Abdel Samad T, Bozzi Y, Baik JH, Borrelli E. Picetti R, et al. Crit Rev Neurobiol. 1997;11(2-3):121-42. doi: 10.1615/critrevneurobiol.v11.i2-3.20. Crit Rev Neurobiol. 1997. PMID: 9209827 Review.
Cited by
- Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.
Sands SA, Dickerson DS, Morris SJ, Chronwall BM. Sands SA, et al. Endocrine. 1997 Jun;6(3):325-33. doi: 10.1007/BF02820510. Endocrine. 1997. PMID: 9368690 - TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg.
Liu JF, Li JX. Liu JF, et al. Front Pharmacol. 2018 Mar 27;9:279. doi: 10.3389/fphar.2018.00279. eCollection 2018. Front Pharmacol. 2018. PMID: 29636691 Free PMC article. Review. - Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells.
Gardner B, Hall DA, Strange PG. Gardner B, et al. Br J Pharmacol. 1996 Jul;118(6):1544-50. doi: 10.1111/j.1476-5381.1996.tb15572.x. Br J Pharmacol. 1996. PMID: 8832084 Free PMC article. - Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors.
Albizu L, Holloway T, González-Maeso J, Sealfon SC. Albizu L, et al. Neuropharmacology. 2011 Sep;61(4):770-7. doi: 10.1016/j.neuropharm.2011.05.023. Epub 2011 May 27. Neuropharmacology. 2011. PMID: 21645528 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources